GRAPPA 2013 Annual Meeting, Rheumatology Updates: Psoriatic Arthritis (PsA) Biomarker Project, Arthritis Mutilans, PsA-Peripheral Spondyloarthritis Epidemiology Project

REFERENCES

1. 1.↵
   1. Wright V,
   2. Moll JMH

   . Seronegative polyarthritis. Amsterdam: North Holland Publishing Co; 1976.
2. 2.↵
   1. McGonagle D,
   2. Conaghan PG,
   3. Emery P

   . Psoriatic arthritis: a unified concept twenty years on. Arthritis Rheum 1999;42:1080–6. Erratum in: Arthritis Rheum 1999;42:1997.

   OpenUrlCrossRef
3. 3.↵
   1. Marsal S,
   2. Armadans-Gil L,
   3. Martinez M,
   4. Gallardo D,
   5. Ribera A,
   6. Lience E

   . Clinical, radiographic and HLA associations as markers for different patterns of psoriatic arthritis. Rheumatology 1999;38:332–7.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. McQueen F,
   2. Lloyd R,
   3. Doyle A,
   4. Robinson E,
   5. Lobo M,
   6. Exeter M,
   7. et al.

   Zoledronic acid does not reduce MRI erosive progression in PsA but may suppress bone oedema: the Zoledronic Acid in Psoriatic Arthritis (ZAPA) Study. Ann Rheum Dis 2011;70:1091–4.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Chandran V,
   2. Thavaneswaran A,
   3. Pellett FJ,
   4. Gladman DD

   . The association between human leukocyte antigen and killer-cell immunoglobulin-like receptor gene variants and the development of arthritis mutilans in patients with psoriatic arthritis [abstract]. Arthritis Rheum 2011;63 Suppl:S532.

   OpenUrl
6. 6.↵
   1. Chandran V,
   2. Gladman DD,
   3. Helliwell PS,
   4. Gudbjornsson B

   . Arthritis mutilans: a report from the GRAPPA 2012 annual meeting. J Rheumatol 2013;40:1419–22.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Taylor W,
   2. Gladman D,
   3. Helliwell P,
   4. Marchesoni A,
   5. Mease P,
   6. Mielants H

   . Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665–73.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Rudwaleit M,
   2. Landewe R,
   3. van der Heijde D,
   4. Listing J,
   5. Brandt J,
   6. Braun J,
   7. et al.

   The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 2009;68:770–6.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Rudwaleit M,
   2. van der Heijde D,
   3. Landewe R,
   4. Listing J,
   5. Akkoc N,
   6. Brandt J,
   7. et al.

   The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;68:777–83.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Rudwaleit M,
    2. van der Heijde D,
    3. Landewe R,
    4. Akkoc N,
    5. Brandt J,
    6. Chou CT,
    7. et al.

    The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011;70:25–31.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Reveille JD,
    2. Witter JP,
    3. Weisman MH

    . Prevalence of axial spondylarthritis in the United States: estimates from a cross-sectional survey. Arthritis Care Res 2012;64:905–10.

    OpenUrlCrossRef
12. 12.↵
    1. Stafford L,
    2. Kane D,
    3. Murphy E,
    4. Duffy T,
    5. Lassere M,
    6. Youssef PP,
    7. et al.

    Psoriasis predicts a poor short-term outcome in patients with spondylarthropathy. Arthritis Rheum 2001;45:485–93.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. van den Berg R,
    2. van Gaalen F,
    3. van der Helm-van Mil A,
    4. Huizinga T,
    5. van der Heijde D

    . Performance of classification criteria for peripheral spondyloarthritis and psoriatic arthritis in the Leiden Early Arthritis Cohort. Ann Rheum Dis 2012;71:1366–9.

    OpenUrlAbstract/FREE Full Text